pancreatic cancer

High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access
Videos
High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access
01/20/2021
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses...
01/20/2021
Journal of Clinical Pathways
AGA Updates Clinical Practice Guideline for Pancreatic Cancer Screening
Guideline Updates
AGA Updates Clinical Practice Guideline for Pancreatic Cancer Screening
06/29/2020
Individuals at high risk for pancreatic cancer should at minimum be considered for screening for the disease, according to a new clinical practice update from the American Gastroenterological Association
Individuals at high risk for pancreatic cancer should at minimum be considered for screening for the disease, according to a new clinical practice update from the American Gastroenterological Association
Individuals at high risk for...
06/29/2020
Journal of Clinical Pathways
Research in Review
Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations
08/11/2017
JCP Editors
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
...
08/11/2017
Journal of Clinical Pathways
Research in Review
Combined Chemotherapy, Radiation Improves Survival in Locally Advanced Pancreatic Cancer
06/03/2017
JCP Editors
The addition of radiation therapy to chemotherapy improved overall survival (OS) in patients with unresected locally advanced pancreatic cancer, according to research presented at the 2017 ASCO Annual Meeting (June...
The addition of radiation therapy to chemotherapy improved overall survival (OS) in patients with unresected locally advanced pancreatic cancer, according to research presented at the 2017 ASCO Annual Meeting (June...
The...
06/03/2017
Journal of Clinical Pathways
Research in Review
Novel Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer
04/11/2017
JCP Editors
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A new...
04/11/2017
Journal of Clinical Pathways
Research in Review
Novel TKI Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer
03/09/2017
JCP Editors
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to a study...
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to a study...
A new...
03/09/2017
Journal of Clinical Pathways
Treatment Protocol for Pancreatic Cancer May Improve Survival
05/28/2016
JCP Editors
Patients with pancreatic cancer formally believed to not be eligible for surgery may in fact benefit from resection, according to findings from two recent studies.   Pancreatic cancer can be an especially...
Patients with pancreatic cancer formally believed to not be eligible for surgery may in fact benefit from resection, according to findings from two recent studies.   Pancreatic cancer can be an especially...
...
05/28/2016
Journal of Clinical Pathways
Research in Review
Clinical Pathway for Borderline Resectable Pancreatic Cancer Improves Survival
02/16/2016
JCP Editors
A clinical pathway developed by South Florida researchers may help to improve clinical outcomes for patients with borderline resectable pancreatic cancer.  Although rare, pancreatic cancer is still the...
A clinical pathway developed by South Florida researchers may help to improve clinical outcomes for patients with borderline resectable pancreatic cancer.  Although rare, pancreatic cancer is still the...
...
02/16/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use